---

Biography

Dr. Rariy is a Chief Health Officer and Senior Vice President of Digital Health at Oncology Care Partners, a first-of-its kind, purpose-built value-based oncology care company leveraging technology to both deliver oncology care and also to provide integrated, high-touch, high-tech whole person oncology care improving patients’ experience and outcomes, while lowering unnecessary spend. She oversees oncology innovation care delivery systems and leads digital transformation, including strategies to leverage AI/ML and emerging technologies. In addition to being a healthcare executive, she is a practicing endocrinologist with a focus on endocrine oncology, investor, keynote speaker, peer reviewed author, and serves on several non-profit and private boards that support the advancement of digital health, technology, and equity. Dr. Rariy has more than 15 years’ experience within the digital health and medical technology industry. Most recently she served as venture partner at Takeda Digital Ventures, Takeda Pharmaceuticals and prior to that held senior executive roles in various markets including pharmaceuticals, government, academic, private, Fortune 5 “Big Tech” (Amazon Care at Amazon, Inc.), to start-up. With such a unique combination of expertise and perspective, she has been recognized by ASCO/AVBCC as “40 under 40” in Cancer Innovation. She is the co-founder of Equity in STEMM, Innovation, & AI, which collaborates with academia, industry, and policymakers to overcome barriers in healthcare and amplify the STEMM (Science, Technology, Engineering, Mathematics, and Medicine) potential throughout communities. Dr. Rariy is board certified in Internal Medicine and Endocrinology, fellowship trained in clinical and research at Harvard Medical School’s Brigham & Women’s Hospital and University of Pittsburgh Medical Center (UPMC), with a medical degree from Harvard Medical School.